Month: September 2024

Hanson brings more than 20 years of experience specializing in organizational design, employee engagement, and workplace culture CAMBRIDGE, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — CarGurus (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jennifer Hanson has been appointed Chief People Officer (CPO), effective September 30, 2024. With more than 20 years of experience in human resources (HR), employee benefits, and law, Hanson will lead CarGurus’ People and Talent team in their work advancing organizational strategies, talent development, and engagement to drive business performance and continued innovation. “CarGurus employees play a key role in our mission to deliver an exceptional customer experience, and I believe Jennifer’s expertise is well-aligned...

Expands available market to include over 200 children’s hospitals in the United States LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its FDA-cleared T2Candida® Panel for pediatric patients. The Company expects to immediately begin marketing and selling the T2Candida Panel under the expanded pediatric claim. The T2Candida Panel is the only FDA-cleared diagnostic test able to detect sepsis-causing Candida species directly-from-blood, in just 3-5 hours, without the need to wait days for a positive blood culture. The T2Candida Panel runs on the FDA-cleared T2Dx® Instrument and simultaneously...

Pathfinder’s capabilities are now available via the cloud, giving law enforcement new deployment options to accelerate justice TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) — Cellebrite (Nasdaq: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today Pathfinder in the Cloud with Amazon Web Services (AWS) (Nasdaq: AMZN), allowing customers to access Cellebrite’s industry-leading investigative analytics solution, Pathfinder, through the secure Amazon Virtual Private Cloud (VPC). Now available for on-premises and cloud use, Pathfinder drastically reduces the hours investigators and analysts spend on cases because its artificial intelligence (AI) capabilities help to swiftly identify meaningful data and connections across multiple devices. It...

VANCOUVER, British Columbia, Sept. 16, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”)(CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group and TerraZero, is pleased to announce that the TSX Venture Exchange (“TSXV”) has approved the Company’s application to list its common shares (the “Shares”) on the TSXV. It is anticipated that the TSXV listing will further increase the Company’s visibility in the capital markets both domestically and globally. The Shares are expected to commence trading on the TSXV effective market open on September 17, 2024. The Company’s trading symbol “BIGG” will remain unchanged and its shareholders will not be required to take any action in connection with BIGG’s listing on the TSXV. The Shares...

In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months SOUTH JORDAN, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive 6-month findings from the randomized arteriovenous (AV) fistula arm of its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial. The data were shown at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) during a FIRST@CIRSE presentation. WRAPSODY is a cell-impermeable endoprosthesis which is intended to extend long-term vessel patency in dialysis patients. Many patients undergoing dialysis rely on a vascular access site created in the arm called an AV fistula. The maintenance of adequate blood flow through this site is crucial for patient survival. The...

SAN DIEGO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced that Kratos Turbine Technologies has successfully completed a ground test campaign of a Cost-Optimized, Limited-Life Turbofan Engine. The engine testing was managed by the Air Force Research Laboratory, Aerospace Systems Directorate, Turbine Engine Division (AFRL/RQT) under the Attritable Cost Optimized Limited Life Engine Technologies (ACOLLET) program. All test plan objectives were achieved including matching pre-test predictions on thrust and fuel efficiency.Turbofan Ground Testing at Kratos’ X-58 Test Facility A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dae25e8a-6434-43d5-8e4c-8b274a92d9da The...